Innovation, Commercialization, and Start-Ups in Life Sciences

Innovation is the process of turning a new method, idea, or product into a reality and profit. Start-ups must have a value proposition that attracts customers, investors, and acquirers, and a high percentage of them fail before attaining positive cashflow. This book discusses the methodologies necessary to create a successful life science start-up, including determining a company valuation and future fundable milestones, aligning regulatory and clinical strategies, and discussing intellectual property derived from a university or individual. It is intended for entrepreneurs, venture capitalists, and investors in both business and academic settings.

Format: Paperback / softback
Length: 196 pages
Publication date: 28 September 2021
Publisher: Taylor & Francis Ltd

Innovation is the process of translating a novel method, idea, or product into a tangible and profitable reality. It encompasses a series of interconnected steps that build a strong brand reputation, essential for success. Unlike Fortune 500 companies, which self-fund their projects, start-ups must simultaneously offer a compelling value proposition that attracts customers, attracts investors, and attracts acquirers for potential liquidity events or IPOs. Unfortunately, a significant percentage of start-ups fail to achieve positive cash flow before reaching this milestone due to various factors outlined in this book.

The primary objective of this book is to guide readers away from the pitfalls and wrong turns that can lead to startup failure. It provides a comprehensive roadmap for creating a successful life science start-up, covering the critical stages from inception to exit. Authored by an experienced professional who has worked with nearly 500 life science start-ups, this book delves into specific processes and investor milestones that must be navigated to align customer, funder, and acquirer needs.

Successful commercialization in the life sciences requires a deep understanding of various stakeholders, including investors, regulators, and customers. Investors seek liquidity for their investment, which is achieved through selling their stock in public or private sales. The reader will gain valuable insights into the necessary data, partnerships, and skills required to build a competitive and sustainable company. The author addresses critical issues such as customer problems, demonstrating sales access, and ensuring intellectual property protection against competitive advancements.

This book is designed to appeal to entrepreneurs, venture capitalists, and investors across both business and academic settings. These organizations typically have specialized departments, such as Research and Development (R&D), Operations, Business Development, Legal, Regulatory, and Marketing, that contribute to the success of their ventures. By leveraging the expertise and insights provided in this book, readers can develop a comprehensive understanding of the challenges and opportunities in the life sciences industry and apply them to their own entrepreneurial endeavors.

Weight: 340g
Dimension: 156 x 235 x 16 (mm)
ISBN-13: 9780367533045
Edition number: 2 New edition